Qatar - QRCS distributes breast cancer treatment drugs in Gaza hospitals
(MENAFN- The Peninsula) The Peninsula
Doha: As part of its ongoing health interventions in Gaza, Qatar Red Crescent Society (QRCS) has provided Palestine's Ministry of Health (MoH) in Gaza with the drugs used to treat breast cancer, with the aim of maintaining treatment and preventing treatment protocol disruptions.
In this context, Dr. Akram Nassar, head QRCS's representation office in Gaza, said the new intervention came to ensure the continuity of treatment services for the patients with breast cancer at MoH hospitals in Gaza, by providing 21 types of chemotherapy drugs that are required on a permanent basis.
This intervention, he explained, is part of the project to provide treatment and rehabilitation services for patients with breast cancer, at a total cost of $864,000.
Assistant Director-General of Pharmacy at Gaza's MoH Dr. Zikri Abu Qamar said the blockade suffered from a medical shortage, especially for cancers, where the shortage in drugs is as much as 50%, seriously affecting the treatment courses and the patients' health conditions.
According to him, QRCS's recent intervention helped to reduce shortage rates to 30%, by securing the treatment services for about 1,400 patients with breast cancer.
Regarding the high number of patients diagnosed with breast cancer in Gaza, Dr. Talha Baalousha, Director of the Blood and Oncology Pharmacy at Rantisi Specialist Hospital, said,“Breast cancer is one of the most widespread cancers in Gaza, with 300 new cases recorded annually. This means a heavier burden on service providers. The new project helped to reduce the rates of referrals for treatment abroad to 50% over the past four months.”
MENAFN06032022000063011010ID1103802090
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.